| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 43.90B | 44.63B | 43.58B | 43.27B | 39.18B | 35.13B |
| Gross Profit | 6.66B | 6.65B | 6.66B | 6.63B | 5.07B | 2.17B |
| EBITDA | 3.94B | 3.63B | 3.50B | 3.48B | 3.89B | 866.00M |
| Net Income | 2.04B | 2.13B | 2.21B | 1.95B | 1.69B | -1.25B |
Balance Sheet | ||||||
| Total Assets | 33.03B | 35.30B | 32.75B | 33.15B | 31.37B | 31.41B |
| Cash, Cash Equivalents and Short-Term Investments | 1.46B | 1.54B | 1.31B | 1.43B | 1.11B | 1.04B |
| Total Debt | 9.40B | 11.95B | 11.65B | 13.66B | 13.48B | 15.48B |
| Total Liabilities | 21.79B | 22.41B | 22.21B | 24.78B | 25.23B | 27.04B |
| Stockholders Equity | 11.12B | 12.76B | 10.45B | 8.32B | 6.07B | 4.22B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 2.02B | 2.16B | 937.00M | 870.00M | -517.00M |
| Operating Cash Flow | 0.00 | 2.95B | 2.92B | 1.57B | 1.31B | -29.00M |
| Investing Cash Flow | 0.00 | -1.01B | -89.00M | -597.00M | 815.00M | 1.76B |
| Financing Cash Flow | 0.00 | -1.72B | -2.88B | -657.00M | -2.12B | -1.77B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | ¥19.44B | 20.28 | ― | 5.16% | 6.58% | ― | |
74 Outperform | ¥14.05B | 6.58 | ― | 1.70% | 0.71% | -14.82% | |
73 Outperform | ¥14.86B | 10.35 | ― | 2.67% | 1.90% | 7.25% | |
68 Neutral | ¥14.12B | 12.43 | ― | 2.82% | 7.95% | 13.67% | |
62 Neutral | ¥18.02B | 16.16 | ― | 2.53% | 4.71% | -0.41% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
61 Neutral | ¥9.03B | 12.60 | ― | 2.04% | 10.87% | 14.80% |